Late Phase Oncology CRO
Global support for late phase oncology trials
Late phase oncology trials help prove whether promising cancer therapies can become marketed options for patients. Worldwide helps sponsors run complex Phase II and III registrational studies with oncology-focused support on a global scale.
Tell us about your study
We’ll connect you with the right oncology clinical
development team.
Your Late Phase Challenges
Built for the Operational Realities of Late Phase Oncology
Late phase oncology trials are driven by the challenges of scale. Sponsors need to generate definitive efficacy, safety, and registrational evidence while coordinating large global studies across regions, sites, vendors, and data streams. Worldwide helps sponsors manage that complexity with oncology-focused operational support, broad global reach, and the experience to keep large studies moving with consistency.
Global Reach Supports Late Phase Scale
Large late phase oncology trials often require broad site activation and patient enrollment across multiple regions. With experience in 70+ countries, Worldwide helps sponsors expand globally and execute with greater consistency across complex study environments.
Cancer Center Access Strengthens Site Strategy
Later-stage oncology studies depend on identifying and activating the right sites at scale. With experience across 1200+ cancer centers globally, Worldwide helps sponsors build site strategies that support enrollment, timelines, and study quality.
Operational Oversight Supports Registrational Goals
Late phase trials require more than global reach alone. Sponsors also need strong oversight across data, regions, and external partners. Worldwide helps teams manage that complexity with a data-centric approach built to support large studies moving toward registration.
Experienced Oncology Teams Help Protect Momentum
Large oncology studies can lose time when study team members lack critical experience or are regularly turning over. Worldwide brings a depth of oncology experience across all functions, and boasts a 91%+ retention rate within the oncology business unit (training 12 months) to help minimize disruption and keep the focus on study milestones.
Partnership & Approach
A Coordinated Approach to Global Execution
Worldwide partners with sponsors to help late phase oncology trials run smoothly across teams, regions, and study partners. Our approach brings together oncology expertise, global delivery support, and clear operational oversight to help sponsors manage site activation, enrollment, logistics, and execution at scale.
Full-Service Oncology
Projects, Past 5 Years
Cancer Centers
Globally
Why Worldwide
What Makes Worldwide the Right Late Phase Oncology Fit?
Worldwide brings the operational reach, oncology focus, and late phase experience sponsors need to run large global studies with stronger coordination, practical execution, and confidence as programs move toward registration.
Built for Global Execution
Worldwide supports global Phase II and III oncology studies with the reach needed to manage execution across North America, Europe, Latin America, the Middle East, North Africa, and Asia-Pacific. That support helps sponsors move large studies forward with in-country expertise paired with global coordination and oversight.
Countries in Key
Global Regions
Broad Site Strategy Support
Late phase oncology studies depend on finding and activating the right sites at scale. Worldwide brings experience with 500+ cancer centers globally, helping sponsors build site strategies that support enrollment and timelines.
Cancer Centers
Globally
Operational Support for Registration
Late-stage oncology trials require operational consistency across regions, teams, and external partners while supporting definitive efficacy and safety evidence. Worldwide brings experience in 70+ countries around the globe to help sponsors manage that complexity.
FDA Approvals
Patient-Centered Practicality at Scale
Even when late phase protocols are simplified, execution still needs to work for real patients and real sites. Worldwide helps sponsors think practically about study burden, feasibility, and operational design in large global trials.
Full-Service Oncology
Projects, Past 5 Years
Data Visibility Across Programs
Large late phase studies generate complexity across sites and regions. Worldwide’s data-centric approach helps sponsors maintain visibility into study performance and feel confident that their data is being monitored and managed with quality to help pass regulatory scrutiny.
Services & Capabilities
Comprehensive Oncology CRO Services
- Protocol Design and Clinical Development Planning
- Regulatory Consulting and Global Submissions
- Global Project Management
- Feasibility Analysis and Site Selection Strategy
- Site Initiation and Study Start-up
- Patient Enrollment
- Dose Escalation, Optimization and Cohort Management
- Site Monitoring and Management
- Data Management
- Clinical Data Analytics and Review
- Clinical Science
- Biostatistics
- Medical Monitoring
- Safety / Pharmacovigilance
- Medical Writing
Global Study Execution
Worldwide helps sponsors manage large late phase oncology trials across regions with support designed to maintain consistency from country to country and site to site.
Site Activation at Scale
Our teams support regulatory and site strategy for late phase oncology studies that require broad activation across cancer centers and investigator networks to meet enrollment goals.
Enrollment Planning
Worldwide helps sponsors plan for the realities of enrolling large patient populations in a competitive trial landscape, with attention to site access, the patient journey, and local standards of care.
Vendor Coordination
Large late stage trials often involve multiple vendors to support a holistic trial. Worldwide helps sponsors coordinate that complexity so execution remains aligned across teams and external providers.
Data Oversight
Late phase oncology programs require strong oversight to build a registrational data package. Worldwide helps sponsors maintain visibility into study performance and emerging issues through a data-centric approach.
What Our Clients Say
“I’ve found that historically, working with a CRO or two that we’ve had, experience within the region has done much better for us, versus going to a large, clunky, multinational CRO that maybe doesn’t have the exact… I don’t want to minimize their know-how, but really doesn’t have the landscape in terms of speed and what they need to do to get us going.”
President, Clinical Operations – Late Phase | Small Biotech (North America)
FAQ & Insights
What Sponsors Need to Know
Worldwide supports late phase oncology trials across all cancer indications and drug modalities. The focus is on helping sponsors run large, complex studies on a global scale that can support a marketing authorization.
Yes. Worldwide is proud to have ~25% of its oncology pipeline focused in late phase development and to have supported 10 FDA approved cancer therapies to date. With experience in 70+ countries, Worldwide is positioned to support Phase III trials across North America, Europe, Latin America, Middle East, North Africa. That reach helps sponsors access sites and patients on a global scale to efficiently enroll successful Phase III trials.
Worldwide is actively interacting with all major regulatory agencies around the world and brings access to 1200+ cancer centers globally. That breadth helps support regulatory submissions and site identification and activation strategies for later-stage oncology studies that depend on the right country, institutional reach and enrollment potential.
Late phase oncology trials often depend on enrolling large patient volumes across many sites and regions. Worldwide helps sponsors plan around those realities through global site reach, real-time knowledge of the competitive landscape and shifting standards of care, and practical study planning built for scale.
Large late phase studies require coordination and communication across time zones, internal teams, sites, regions, and external partners. Worldwide helps sponsors manage that complexity through in-country experts paired with regional and global oversight to provide a collaborative approach focused on consistency, transparency, and practical execution across the study environment.
Worldwide brings a data-centric approach to oncology trial execution, helping sponsors maintain visibility into study performance and make informed decisions as large programs progress. This is especially important in late phase trials, where operational and clinical data volume can increase quickly.
Late phase oncology trials are driven more by the operational challenges of scale than by first-in-human or proof-of-concept agility. The emphasis is on generating definitive efficacy, safety, and registrational evidence while coordinating large numbers of sites, patients, regions, and partners.
Recruiting large numbers of patients in late phase oncology trials requires more than broad site reach alone. Sponsors also need a study that is realistic for patients, caregivers, and sites to deliver at scale. Worldwide helps sponsors think practically about enrollment strategy, study burden, and operational feasibility in global late phase programs.
Insights
Explore Our Late Phase Oncology Insights
Oncology Expertise
Looking for Other Oncology Specializations?
See what Worldwide Clinical Trials can do for you.
Your study has unique goals, risks, and decisions ahead. Tell us a little about your needs, and our team will connect you with the right Worldwide experts to discuss how our scientific, medical, and operational support can help move your program forward with confidence.
